PREDICTMEDIX AI INC. Financials Predictmedix AI Inc. Deutsche Boerse AG
Equities
3QP0
CA74040N1069
Industrial Machinery & Equipment
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.013 EUR | +30.00% |
|
+36.84% | -43.48% |
| 05-31 | Predictmedix AI Inc. Reports Earnings Results for the Full Year Ended January 31, 2024 | CI |
| 04-25 | Predictmedix Inc. Expands Reach and Impact in Healthcare Transformation Efforts | CI |
Valuation
| Fiscal Period: January | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Capitalization 1 | 12.99 | 26.96 | 13.09 | 8.544 | 9.767 |
| Enterprise Value (EV) 1 | 11.52 | 26.48 | 12.87 | 8.502 | 9.73 |
| P/E ratio | -5.34 x | -17 x | -6.88 x | -3.87 x | -4.66 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | - | 97,063,900 x | 243,963,164 x | - |
| EV / Revenue | - | - | 95,496,610 x | 242,781,553 x | - |
| EV / EBITDA | -14.7 x | -14.2 x | -7.51 x | -4.45 x | -5.2 x |
| EV / FCF | -33,955,724 x | -56,748,241 x | -11,190,990 x | 50,871,228 x | -11,438,646 x |
| FCF Yield | -0% | -0% | -0% | 0% | -0% |
| Price to Book | 7.9 x | 31 x | 14.8 x | -55.7 x | -67.9 x |
| Nbr of stocks (in thousands) | 103,954 | 101,718 | 109,051 | 122,051 | 150,260 |
| Reference price 2 | 0.1250 | 0.2650 | 0.1200 | 0.0700 | 0.0650 |
| Announcement Date | 01/06/20 | 31/05/21 | 31/05/22 | 31/05/23 | 30/05/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: January | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net sales | - | - | - | 0.1348 | 0.035 | - |
| EBITDA 1 | -0.3099 | -0.7843 | -1.869 | -1.715 | -1.911 | -1.872 |
| EBIT 1 | -0.3137 | -0.7915 | -1.873 | -1.732 | -1.947 | -1.913 |
| Operating Margin | - | - | - | -1,284.4% | -5,560.75% | - |
| Earnings before Tax (EBT) 1 | -0.3121 | -2.311 | -1.931 | -1.882 | -2.068 | -1.993 |
| Net income 1 | -0.2746 | -2.292 | -1.582 | -1.882 | -2.068 | -1.993 |
| Net margin | - | - | - | -1,396.07% | -5,904.5% | - |
| EPS 2 | -0.004787 | -0.0234 | -0.0156 | -0.0174 | -0.0181 | -0.0139 |
| Free Cash Flow | - | -0.3391 | -0.4665 | -1.15 | 0.1671 | -0.8506 |
| FCF margin | - | - | - | -853.33% | 477.25% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 12/12/19 | 01/06/20 | 31/05/21 | 31/05/22 | 31/05/23 | 30/05/24 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: January | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 1.56 | 1.48 | 0.48 | 0.21 | 0.04 | 0.04 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | -0.34 | -0.47 | -1.15 | 0.17 | -0.85 |
| ROE (net income / shareholders' equity) | - | -142% | -157% | -214% | -564% | 1,341% |
| ROA (Net income/ Total Assets) | - | -29.1% | -87.7% | -96.6% | -125% | -199% |
| Assets 1 | - | 7.866 | 1.804 | 1.948 | 1.66 | 0.9997 |
| Book Value Per Share 2 | 0.0200 | 0.0200 | 0.0100 | 0.0100 | -0 | -0 |
| Cash Flow per Share 2 | 0.0200 | 0.0100 | 0 | 0 | 0 | 0 |
| Capex 1 | 0.02 | 0.01 | - | 0.08 | 0.09 | - |
| Capex / Sales | - | - | - | 62.86% | 270.78% | - |
| Announcement Date | 12/12/19 | 01/06/20 | 31/05/21 | 31/05/22 | 31/05/23 | 30/05/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +0.77% | 30.43B | |
| +26.94% | 8.77B | |
| +12.03% | 8.03B | |
| +20.72% | 5.48B | |
| +13.27% | 3.71B | |
| -19.32% | 3.46B | |
| +3.41% | 3.4B | |
| +17.68% | 3.38B | |
| -10.25% | 2.7B |
- Stock Market
- Equities
- PMED Stock
- 3QP0 Stock
- Financials Predictmedix AI Inc.
